These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 10148469)
1. Chronic obstructive pulmonary disease in European insureds. Fessel M J Insur Med; 1991; 23(1):38-40. PubMed ID: 10148469 [No Abstract] [Full Text] [Related]
2. Mortality from chronic obstructive pulmonary disease. Buechner JS Med Health R I; 1996 Mar; 79(3):116-7. PubMed ID: 8901294 [No Abstract] [Full Text] [Related]
3. Mortality in and prevalence of chronic obstructive pulmonary disease in different parts of Europe. Gulsvik A Monaldi Arch Chest Dis; 1999 Apr; 54(2):160-2. PubMed ID: 10394832 [TBL] [Abstract][Full Text] [Related]
4. Trends in chronic obstructive pulmonary disease mortality. Miller N; Simoes EJ; Chang JC; Robling AG Mo Med; 2000 Mar; 97(3):87-90. PubMed ID: 10745650 [TBL] [Abstract][Full Text] [Related]
5. Chronic obstructive pulmonary disease. Rasmussen DL W V Med J; 2001; 97(1):23-6. PubMed ID: 11257831 [No Abstract] [Full Text] [Related]
12. [A role of the endothelium in the development of pulmonary hypertension in patients with chronic obstructive lung diseases]. Karoli NA; Rebrov AP Klin Med (Mosk); 2004; 82(8):8-14. PubMed ID: 15468716 [No Abstract] [Full Text] [Related]
13. Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Rivera-Fernández R; Navarrete-Navarro P; Fernández-Mondejar E; Rodriguez-Elvira M; Guerrero-López F; Vázquez-Mata G; Crit Care Med; 2006 Sep; 34(9):2317-24. PubMed ID: 16849998 [TBL] [Abstract][Full Text] [Related]
14. [The role of renin-angiotensin system in pathogenesis of pulmonary hypertension in patients with chronic obstructive pulmonary disease]. Frangulian RR Klin Med (Mosk); 2000; 78(10):18-20. PubMed ID: 11220892 [TBL] [Abstract][Full Text] [Related]
15. Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non-small cell lung cancer. Subotic DR; Mandaric DV; Eminovic TM; Gajic MM; Mujovic NM; Atanasijadis ND; Dzeletovic PP; Andric LD; Bulajic BM; Dimitrijevic ID; Sobic DP J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1292-9. PubMed ID: 17976465 [TBL] [Abstract][Full Text] [Related]
16. A breath of fresh air for COPD. Quartararo P J Insur Med; 2008; 40(1):20-5. PubMed ID: 18924363 [No Abstract] [Full Text] [Related]
17. Pricing implications of trends in population mortality and underwriting effectiveness. Pokorski RJ J Insur Med; 2004; 36(1):54-9. PubMed ID: 15104030 [TBL] [Abstract][Full Text] [Related]
18. [Inpatient treatment costs of exacerbated chronic obstructive lung disease]. Riecke K; Eller J; Gericke C; Lode H Pneumologie; 1999 Apr; 53(4):199-206. PubMed ID: 10409862 [TBL] [Abstract][Full Text] [Related]
19. COPD stories of complex causal 'truths' 'Sure I've smoked all my life/but I also put in 37 years at the mine'. Bailey PH; Montgomery P; Boyles CM J Clin Nurs; 2009 Jul; 18(14):1994-2002. PubMed ID: 19374690 [TBL] [Abstract][Full Text] [Related]
20. [Is nebulized ipratropium bromide effective in the treatment of exacerbations of chronic obstructive pulmonary disease?]. Musil J Vnitr Lek; 2000 Jan; 46(1):45-8. PubMed ID: 10953664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]